Rezulin troglitazone: Phase II; marketed to treat Type II diabetes

By WIR Staff | Apr 5, 1999 | 7:00 AM GMT

Dana-Farber Cancer Institute researchers and colleagues published in the Proceedings

Read the full 103 word article

How to gain access

Continue reading with a
two-week free trial.